Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Merck KGaA

Merck scraps MS pill cladribine

June 23, 2011 Research and Development, Sales and Marketing Cladribine, Merck KGaA, Movectro, multiple sclerosis

Merck KGaA has pulled all pending applications for its multiple sclerosis pill Movectro and will withdraw it from the markets …
News

Sanofi to boost early-stage research with ‘real world’ evidence

June 23, 2011 Research and Development Sanofi, patient data, pharma research

Sanofi is aiming to maximise its R&D investment by including ‘real world’ evidence in its product development strategy. The company …
News
Novartis

FDA rejects Novartis’ Ilaris for gouty arthritis

June 22, 2011 Research and Development Ilaris, Novartis, gouty arthritis

An FDA advisory panel has voted against backing Novartis’ Ilaris for gouty arthritis because of safety concerns. Ilaris (canakinumab) is …
News

Careers in next generation contract partnering

June 22, 2011 Business Services, Manufacturing and Production, Research and Development contract manufacturing, contract research, cros

Over the past few years, a significant shift has occurred in the depth and type of relations that the pharma …
Feature
Neurotune chief executive Bruno Oesch

Working Life: Neurotune’s chief executive

June 22, 2011 Business Services, Research and Development Working Life, recruitment

Bruno Oesch, chief executive of Swiss biopharmaceutical company Neurotune, talks to Pharmafocus about being at the interface of science and …
News
rocheroof

Mid-stage trial boost for Roche skin cancer drug vismodegib

June 20, 2011 Research and Development Cancer, Roche, skin cancer, vismodegib

Roche’s novel skin cancer drug vismodegib has met its primary endpoint in a phase II trial. Vismodegib is an investigational, …
News

Actelion plans biotech start-up

June 20, 2011 Research and Development Actelion, biotech

Swiss biopharmaceutical company Actelion is planning to launch a biotech start-up that would run separately from the main company. It …
News

Stem cell trial aims to cure macular degeneration

June 17, 2011 Research and Development AMD, Advanced Cell Technology, Stargardt’s Macular Dystrophy, Stem cells, stem cell

A groundbreaking trial to explore the use of stem cells to treat macular degeneration has been launched. US company Advanced …
News
AstraZeneca

AZ establishes predictive science centre in Russia

June 17, 2011 Research and Development AstraZeneca, Russia, predictive science

AstraZeneca is moving further into Russia with the establishment in St. Petersburg of a facility which aims to better assess …
News

Biocair appoints new business development managers

June 16, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Biocair has appointed two new business development managers, Natalie Gerrard and Steve Taylor. Natalie Gerrard was promoted internally from within …
Appointment
Sanofi headquarters

Sanofi signs regenerative medicines collaboration

June 16, 2011 Research and Development Audion, Sanofi, hearing loss

Sanofi has signed a research pact with Audion Therapeutics to develop regenerative medicines for hearing loss. The company’s two-year deal …
News

GSK takes control of China vaccines venture

June 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines

GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …
News

Arecor and GSK collaborate on vaccine technology

June 15, 2011 Manufacturing and Production, Research and Development Arecor, GSK, vaccines

GSK is to team up with UK company Arecor to develop advanced formulations of GSK’s vaccines. Cambridge-based Arecor has developed …
News
ABPI social media internet guidelines

Digital Pharma: Pharmacovigilance, the internet and social media

June 15, 2011 Medical Communications, Research and Development, Sales and Marketing Digital Pharma blog, adverse event reporting, adverse events, pharmacovigilance

This week the ABPI released guidance on managing adverse events from social media and the internet in a document that …
Feature
Cephalon

Teva’s Cephalon acquisition could be delayed

June 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Cephalon, Teva

The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month. …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025